What is Chongqing Zhifei Biological Products Co., Ltd.'s (300122.SZ) StockRank?

MoatMap's StockRank for Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) is 25/100, with a Sell signal. This is a composite score combining Quality (30), Value (56), and Momentum (30) factor ranks across MoatMap's 20,000+ stock universe.

Does Chongqing Zhifei Biological Products Co., Ltd. have an economic moat?

Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Chongqing Zhifei Biological Products Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) is Sell, based on a StockRank of 25/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Chongqing Zhifei Biological Products Co., Ltd. in?

Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300122.SZ

SELLREMOVE

Chongqing Zhifei Biological Products Co., Ltd. · Healthcare · China · $4.8B · Avg Vol: $42M/d

StockRank

P/E (TTM)

—

ROE

-64.1%

D/E

0.7x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Chongqing Zhifei is highly dependent on its distribution agreement for Merck's HPV vaccine, leaving it vulnerable to contract renegotiation and domestic competition with no proprietary moat.

COMPANY DESCRIPTION

Chongqing Zhifei Biological Products Co., Ltd. develops, produces, and distributes biopharmaceutical products, specializing in human vaccines. The company is the largest private vaccine enterprise in China, driven by its exclusive distribution rights for Merck's blockbuster HPV and rotavirus vaccines alongside its proprietary pipeline. Its extensive cold-chain logistics network and deep penetration into China's public health centers constitute an unmatched competitive moat.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	5.7B	7.8B	3.8B	1.3B	-38.4%
EPS	0.46	0.50	0.12	-0.91	-48.8%
Shares	2.5B	2.4B	2.4B	2.4B	-2.8%
Debt	300M	449M	2.0B	1.8B	82.1%
Equity	3.6B	4.7B	4.6B	2.3B	-13.2%
Op CF	294M	1.3B	-624M	764M	37.5%
Inv CF	-221M	-144M	-178M	-88M	—
Fin CF	-321M	-635M	264M	-699M	—

PRICE (1M)-20.8%

SMA 50SMA 200

$1.81

RSI (14)

30.2

52W High

$3.84

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

-88.8%6.0

ROE

-64.1%13.5

GP/Assets

-41.3%1.7

Op. Margin

-15.6%27.5

FCF/Assets

32.5%97.9

Piotroski

—55.7

Int. Cover

-50.0x6.4

D/E Ratio

0.72x22.1

Current Ratio

3.14x55.3

Value

P/E (TTM)

—N/A

EV/EBITDA

-2.4x68.0

P/FCF

21.5x97.4

P/B

1.9x57.0

P/S

3.4x53.2

Div Yield

—N/A

Momentum

52W High %

47%20.7

RS 6M

-48%23.6

SMA 50/200

0.79x12.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+124%77.7

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$4.8B

P/E (Forward)

8.2x

Gross Margin

-149.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300122.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300122.SZ	Chongqing Zhifei Biological Products Co., Ltd.(you)	$4.8B	25	SELL
688180.SS	Shanghai Junshi Biosciences Co., Ltd.	$5.2B	25	SELL
688266.SS	Suzhou Zelgen Biopharmaceuticals Co., Ltd.	$3.9B	28	SELL
603392.SS	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	$6.5B	22	SELL
002252.SZ	Shanghai RAAS Blood Products Co., Ltd.	$5.2B	34	SELL
9688.HK	Zai Lab Limited	$2.0B	24	SELL
688796.SS	BIOCYTOGEN PHARMACEUTICALS (BEI	$7.2B	13	STRONG SELL
9995.HK	RemeGen Co., Ltd.	$6.3B	40	HOLD
688428.SS	InnoCare Pharma Limited	$6.4B	40	HOLD
2696.HK	Shanghai Henlius Biotech, Inc.	$4.8B	45	HOLD

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) — Stock Score Summary

Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) has a MoatMap StockRank of 25/100 based on Quality (30/100), Value (56/100), and Momentum (30/100) factor scores. The current signal is SELL. Chongqing Zhifei is highly dependent on its distribution agreement for Merck's HPV vaccine, leaving it vulnerable to contract renegotiation and domestic competition with no proprietary moat.

Key Financial Metrics

Price	$1.81
Market Cap	$4.8B
P/E (Forward)	8.19
Price/Book	1.91
Return on Equity	-64.1%
Return on Invested Capital	-88.8%
Debt/Equity	71.94
Gross Margin	-149.0%
Operating Margin	-15.6%
Revenue Growth	-8.6%
Free Cash Flow	$224M

Chongqing Zhifei Biological Products Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Chongqing Zhifei Biological Products Co., Ltd.’s (300122.SZ) StockRank?: MoatMap’s StockRank for Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) is 25/100, with a Sell signal. It is a composite of Quality (30), Value (56), and Momentum (30) factor ranks across MoatMap’s 20,000+ stock universe.
Does Chongqing Zhifei Biological Products Co., Ltd. have an economic moat?: Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Chongqing Zhifei Biological Products Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) is Sell, based on a StockRank of 25/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Chongqing Zhifei Biological Products Co., Ltd. in?: Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).